No Data
Jefferies Maintains Brookdale Senior Living(BKD.US) With Buy Rating, Maintains Target Price $8
RBC Capital Maintains Brookdale Senior Living(BKD.US) With Buy Rating, Maintains Target Price $8
Macquarie Maintains Brookdale Senior Living(BKD.US) With Buy Rating, Announces Target Price $8
Analysts' Top Healthcare Picks: Brookdale Senior Living (BKD), Santhera Pharmaceuticals Holding (SPHDF)
Express News | Macquarie Maintains Outperform on Brookdale Senior Living, Maintains $8 Price Target
Express News | RBC Capital Reiterates Outperform on Brookdale Senior Living, Maintains $8 Price Target